{
    "2020-10-06": [
        [
            {
                "time": "2020-11-01",
                "original_text": "Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "Moderna",
                        "vaccine",
                        "data readouts"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-01",
                "original_text": "U.S. vaccine program head Slaoui expects Pfizer, Moderna vaccine data readouts in Nov-Dec",
                "features": {
                    "keywords": [
                        "Slaoui",
                        "Pfizer",
                        "Moderna",
                        "vaccine",
                        "data readouts"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-03",
                "original_text": "Here's Why BioNTech's Stock Price Jumped Today",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "stock price",
                        "jumped"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-30",
                "original_text": "Why Exelixis Jumped 10% in September",
                "features": {
                    "keywords": [
                        "Exelixis",
                        "jumped",
                        "September"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-24",
                "original_text": "US STOCKS-Tech sell-off weighs on Wall St as Powell warns on recovery",
                "features": {
                    "keywords": [
                        "Tech sell-off",
                        "Wall St",
                        "Powell",
                        "recovery"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-15",
                "original_text": "Russian COVID-19 vaccine trials have yet to start in Brazil, lagging rivals",
                "features": {
                    "keywords": [
                        "Russian",
                        "COVID-19",
                        "vaccine",
                        "trials",
                        "Brazil",
                        "lagging"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-20",
                "original_text": "Pfizer CEO says won't discuss FDA's coronavirus vaccine guidance with White House",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CEO",
                        "FDA",
                        "coronavirus",
                        "vaccine",
                        "guidance",
                        "White House"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-25",
                "original_text": "EU Regulators Undertake Rolling Review of Pfizer and BioNTech Vaccine Candidate",
                "features": {
                    "keywords": [
                        "EU",
                        "Regulators",
                        "Rolling Review",
                        "Pfizer",
                        "BioNTech",
                        "Vaccine Candidate"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-24",
                "original_text": "US STOCKS-S&P, Nasdaq dip as Powell warns on economic recovery",
                "features": {
                    "keywords": [
                        "S&P",
                        "Nasdaq",
                        "dip",
                        "Powell",
                        "economic recovery"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-10",
                "original_text": "U.S. FDA asks COVID-19 vaccine developers for two months of safety data",
                "features": {
                    "keywords": [
                        "FDA",
                        "COVID-19",
                        "vaccine",
                        "developers",
                        "safety data"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-05",
                "original_text": "COVID-19 vaccine may be ready by year-end - WHO's Tedros",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "vaccine",
                        "ready",
                        "year-end",
                        "WHO",
                        "Tedros"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-28",
                "original_text": "US STOCKS-S&P, Dow muted with eyes on more stimulus, Powell address",
                "features": {
                    "keywords": [
                        "S&P",
                        "Dow",
                        "muted",
                        "stimulus",
                        "Powell"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}